VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds

Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
You are here : IndiaNotes >> Research & Analysis >> Companies >> Natco Pharma Ltd. >> Research

Jainam's strong investment pick: Buy Natco Pharma on every dips in coming 3 years

Jainam Research | 26 Sep, 2016  | Follow Author | Add to my Favourites 
  • Rate this article
    (Average Rating 0.0 Based on 0 ratings)

Strong Investment Pick: We at Jainam Wealth recommend to our investors to Buy Natco Pharma Ltd. (BSE : 524816) on every dips from CMP of Rs.628 for Target of Rs.950, in the coming 3 years. The company having a strong presence in oncology & gastro hepatology with diverse portfolio of  28 products. Company has filed 38 ANDAs from which still 21 ANDAs pending which is worth of around Rs. 103388 crore. Company having strong partnership with Mylan, Alvogen, Dr.reddy’s, Breckenridge Pharma, Lupin and Actavis and also having robust financial such as zero debt status, RoCE (%)  of 17.87% in FY16 and PATM (%) of 13.04% in FY16.


778.40 +11.55
778.15 +11.55
Read More
About Jainam Research

Jainam Research was incorporated in 2003 with the vision to be the most preferred organization providing all financial services across the country. The foundation is on "Value" Systems - "Value" addition to Corporate, Retails and HNI Individuals through superior Wealth Creation Practices.


For more information please write in to [email protected]

Disclaimer: The author has taken due care and caution to compile and analyse the data. The opinions expressed above are only the views of the author, and not a recommendation to buy or sell. Neither the author nor accept any liability whatsoever arising from the use of any of the above contents.

Technical Calls

What are technical calls?

Other Articles

Have a question?

Investment Advisory Company - Financial Market Research and Consulting